DANA CASTRO: Open Payments
NPI 1770501108 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 33 payments from 9 companies in 2025. Trend: 2023 $279 · 2024 $437 · 2025 $759
Food & beverage: $659Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $164 |
| Alkermes, Inc. | 8 | $148 |
| Janssen Pharmaceuticals, Inc | 8 | $142 |
| Neurocrine BioSciences, Inc. | 4 | $115 |
| Boston Scientific Corporation | 2 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Braeburn Inc. | 1 | $17 |
Products named: ARISTADA, INVEGA SUSTENNA, INGREZZA, WaveWriter Alpha Prime 16, AUSTEDO XR, CAPLYTA, COBENFY, HETLIOZ.
Industry payments across FL — which companies pay providers there.
